These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19711319)

  • 21. Ginkgo is not a smart pill.
    Lazar PA
    J Fam Pract; 2002 Nov; 51(11):912. PubMed ID: 12485537
    [No Abstract]   [Full Text] [Related]  

  • 22. Gender- and age-related variations in blood viscosity in normal volunteers: a study of the effects of extract of Allium sativum and Ginkgo biloba.
    Galduróz JC; Antunes HK; Santos RF
    Phytomedicine; 2007 Aug; 14(7-8):447-51. PubMed ID: 17618098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ginkgo biloba for dementia: a reasonable alternative?
    Wincor MZ
    J Am Pharm Assoc (Wash); 1999; 39(3):415-6. PubMed ID: 10363472
    [No Abstract]   [Full Text] [Related]  

  • 24. [Primary degenerative dementia: therapy with Ginkgo biloba extract. Placebo-controlled double-blind and comparative study].
    Weitbrecht WU; Jansen W
    Fortschr Med; 1986 Mar; 104(9):199-202. PubMed ID: 3516818
    [No Abstract]   [Full Text] [Related]  

  • 25. A randomized controlled pilot trial: the effects of EGb 761 on information processing and executive function in multiple sclerosis.
    Diamond BJ; Johnson SK; Kaufman M; Shiflett SC; Graves L
    Explore (NY); 2013; 9(2):106-7. PubMed ID: 23452713
    [No Abstract]   [Full Text] [Related]  

  • 26. [Nootropic drugs: definition, classification, mechanism of action, clinical effectiveness, substances].
    Kuhlmey J
    Z Arztl Fortbild (Jena); 1994 Sep; 88(9):697-701. PubMed ID: 7975756
    [No Abstract]   [Full Text] [Related]  

  • 27. [Tanakan (EGb 761) in the therapy of mild cognitive impairment].
    Iakhno NN; Zakharov VV; Lokshina AB; Gavrilova SI; Fedorova IaB; Gustov AV; Korshunova IuA; Dziak LA; Miziakina EV; Odinak MM; Emelin AIu; PilipenkoP I ; Vostrikova EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(12):41-6. PubMed ID: 17274394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bleeding caused by Ginkgo biloba extract?].
    Kloft C; Kellermann A
    Pharm Unserer Zeit; 2009; 38(5):440-6. PubMed ID: 19711320
    [No Abstract]   [Full Text] [Related]  

  • 29. [Also true for healthy persons! Longer mental fitness with ginkgo].
    MMW Fortschr Med; 2004 May; 146(21):62. PubMed ID: 15373092
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapy of brain function disorders in the elderly. Proven therapeutic results with Ginkgo-biloba extract in degenerative and vascular dementia. Report of a symposium. Munich, 7 December 1990].
    Fortschr Med Suppl; 1991; 107():1-19. PubMed ID: 1672525
    [No Abstract]   [Full Text] [Related]  

  • 31. [How to correctly use herbs].
    Bonaccorsi A
    Assist Inferm Ric; 2007; 26(4):219-26. PubMed ID: 18297986
    [No Abstract]   [Full Text] [Related]  

  • 32. [Intellectual decline: normal or already pathological. Implementing IGeL dementia diagnosis!].
    MMW Fortschr Med; 2002 Apr; 144(15):65. PubMed ID: 12013036
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effects of Ginkgo biloba extract on functional brain activity.. An assessment of clinical and experimental studies].
    Pidoux B
    Presse Med; 1986 Sep; 15(31):1588-91. PubMed ID: 2947107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of angiodystrophic skin diseases with ginkgo-biloba].
    Nazzaro P; Di Carlo A
    Minerva Med; 1973 Nov; 64(79 Suppl):4198-200. PubMed ID: 4592297
    [No Abstract]   [Full Text] [Related]  

  • 35. [The clinical application of Ginkgo biloba in dementia syndromes (restoration of brain performance in vascular or degenerative CNS disease)].
    Herrschaft H
    Pharm Unserer Zeit; 1992 Nov; 21(6):266-75. PubMed ID: 1287671
    [No Abstract]   [Full Text] [Related]  

  • 36. [Experience in clinical use of tanakan in the treatment of the syndrome of mild cognitive impairment].
    Gavrilova SI; Fedorova IaB; Roshchina IF; Kolykhalov IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(10):42-6. PubMed ID: 17117673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comment on Ginkgo biloba for mild to moderate dementia in a community setting by McCarney et al.
    Hindmarch I
    Int J Geriatr Psychiatry; 2009 Feb; 24(2):214-5; author reply 213. PubMed ID: 19153967
    [No Abstract]   [Full Text] [Related]  

  • 38. An example for an underpowered study: a comment on Ginkgo biloba for mild to moderate dementia in a community setting by McCarney et al.
    Gaus W
    Int J Geriatr Psychiatry; 2009 Feb; 24(2):216-7; author reply 213. PubMed ID: 19153965
    [No Abstract]   [Full Text] [Related]  

  • 39. [The phenomenon of different study results. Were the research participants too old?].
    Röhm W
    MMW Fortschr Med; 2009 Jan; 151(1-2):7. PubMed ID: 19227629
    [No Abstract]   [Full Text] [Related]  

  • 40. Ginkgo thrives.
    Schmid W
    Nature; 1997 Apr; 386(6627):755. PubMed ID: 9126724
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.